---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : MDA231 cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 4

control   :
    - GSM1024695 1
    - GSM1024696 1
    - GSM1024697 1
perturbed :
    - GSM1024698 1
    - GSM1024699 1
    - GSM1024700 1

---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : MDA231 cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1024695 1
    - GSM1024696 1
    - GSM1024697 1
perturbed :
    - GSM1024701 1
    - GSM1024702 1
    - GSM1024703 1

---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : BT549 cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 4

control   :
    - GSM1024704 1
    - GSM1024705 1
    - GSM1024706 1
perturbed :
    - GSM1024710 1
    - GSM1024711 1
    - GSM1024712 1

---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : BT549 cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1024704 1
    - GSM1024705 1
    - GSM1024706 1
perturbed :
    - GSM1024713 1
    - GSM1024714 1
    - GSM1024715 1

---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : SUM159PT cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 4

control   :
    - GSM1024719 1
    - GSM1024720 1
    - GSM1024721 1
perturbed :
    - GSM1024722 1
    - GSM1024723 1
    - GSM1024724 1

---
accession : E-GEOD-41816
platform  : A-GEOD-11532
pathway   : MAPK
cells     : SUM159PT cells transfected with DUSP4 siRNA for 96 h
treatment : selumetinib
effect    : inhibiting
hours     : 24

control   :
    - GSM1024719 1
    - GSM1024720 1
    - GSM1024721 1
perturbed :
    - GSM1024725 1
    - GSM1024726 1
    - GSM1024727 1
...
